Senior Director, Global Medical Affairs, Lung
2 days ago
Senior Director, Global Medical AffairsRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.The Opportunity:Reporting to the Lung Cancer Medical Affairs Strategy Lead, the Senior Director, Global Medical Affairs, will be responsible for developing and executing the Global Medical Affairs (GMA) strategy and tactical plans with a focus on launch readiness and life cycle management for an individual asset. The successful candidate will have a proven track record of developing and driving medical strategy with a focus on effectively communicating key scientific data through publications, medical information, medical communications, and congress activities as well as gathering insights through Advisory Boards and Key Opinion Leader (KOL) engagements. He/she must work collaboratively with cross-functional counterparts in Development, Research and Commercial as well as other partners in the organization to design and implement a comprehensive NSCLC strategy.Key responsibilities:Leads the development and execution the GMA strategy and medical objectives including activities related to scientific engagement and communication, evidence generation, internal education, and patient advocacy.Leads the development and execution of a Health Care Professional (HCP) engagement strategy to gather insights to shape internal programs.Acts as the medical representative on cross-functional teamsServes as a therapeutic area content expert.Participates in the Global Medical Affairs Team (GMAT) to execute medical strategies, contribute to the operations and oversight of medical activities, and work cross-functionally to support associated pre-launch activities.Contributes to the execution of routine gap assessments leading to the development/refinement of a publication strategy, an evidence generation plan, and tactical plan as part of the overall GMA plan.Provides medical leadership in scientific engagement activities with key external stakeholders through organizing and leading advisory boards, studies investigator interactions, congress activities, and peer-to-peer discussions with the goal of communicating scientific insights to internal teams to drive strategy.Communicates clinical and scientific data to KOLs and other healthcare professionals through presentations, educational programs, and scientific discussions.Represents various medical affairs functions in cross-functional strategy team meetings including Clinical and Safety sub-teams, Global Brand Team, Global Product Team, Patient Advocacy, Market Access, and other cross-functional strategic discussions.Partners with the Clinical and MSL teams to provide enrollment, scientific, and engagement support to ensure clinical trials meet study timelines.Partners with RWE strategy and Biomarker/CDx teams on related integrated evidence generation strategies and activities as part of the GMA Plan.Partners with the Patient Advocacy and Grants teams to incorporate the patient voice and define external medical education strategies for independent grants, respectively.Provides medical expertise for scientific symposia and medical congresses and collaborate across GMA functions to develop, review, and align on key scientific communication points and medical information response documents within legal and compliance guidelines.Plays a key role in the review and approval of abstracts, manuscripts, corporate communications, and other data disclosure documents as well as internal stakeholder medical education activities related to the compound data and related competitor data.Partners with stakeholders across the organization, including, but not limited to, Clinical Development and Operations, Commercial Operations, Program Management, Business Development, Regulatory, Safety, and Compliance teams.Required Skills, Experience and Education:An advanced doctorate degree (PharmD, PhD, MD, DO or equivalent) in medical/scientific area is required.14+ years of relevant experience in the biotech or pharmaceutical industry focused on Medical Affairs, with global cross-functional in-house experience and on field-based teams.Must have a strong scientific background in lung cancer with a good understanding of biomarker-driven disease and ability to effectively analyze, synthesize, and communicate complex scientific information.Direct, hands-on experience executing the activities of various functions within medical affairs (training, medical communications, medical information, expanded access programs, evidence generation, publications).Proven track record of clinical trial support including protocol development/review, site selection support, enrollment support, and data analysis.Excellent interpersonal, written, and presentation skills with the ability to effectively communicate complex scientific data with a strong point of view to diverse audiences.Thrives in fast-paced, dynamic environment and ability to multi-task independently with limited supervision.Ability to travel to Redwood City headquarters and professional congresses (30 - 40%).Strong networking skills with deep existing relationships with lung cancer healthcare professionals including global top key opinion leaders required.Preferred Skills:Experience in global product launches including support of integrated brand plan ideation, regulatory submissions, reimbursement, and label development.Experience in guideline submissions (e.g. NCCN) and engagements with global health authorities preferred
-
Director, Global Medical Affairs, Lung
3 weeks ago
Redwood City, United States Revolution Medicines Full timeRevolution Medicines Director, Global Medical AffairsRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with...
-
Director, Global Medical Affairs, Lung
3 weeks ago
Redwood City, CA, United States Revolution Medicines Full timeRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment...
-
Director, Global Medical Affairs, Lung
2 weeks ago
Redwood City, CA, United States Revolution Medicines Full timeRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‐addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment...
-
Director, Global Medical Affairs, Lung
2 weeks ago
Redwood City, CA, United States Revolution Medicines Full timeRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‐addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment...
-
Director, Global Medical Affairs, Lung
3 weeks ago
Redwood City, CA, United States Revolution Medicines Full timeRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment...
-
Director, Global Medical Affairs
3 weeks ago
Redwood City, CA, United States Revolution Medicines Full timeA leading oncology company seeks a Director, Global Medical Affairs to drive the GMA strategy focused on lung cancer therapies. You will engage with healthcare professionals, oversee scientific communications, and collaborate across functions to support clinical trials and product launches. The ideal candidate holds an advanced doctorate and brings over 10...
-
Director, Global Medical Affairs, Lung
3 weeks ago
Redwood City, CA, United States Revolution Medicines Full timeRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RASaddicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies....
-
Director, Global Regulatory Affairs
4 weeks ago
Redwood City, United States Nevro Full timeDirector, Global Regulatory Affairs (Hybrid role)Pay $190000.00 - $262000.00 / yearLocation: Redwood City, CaliforniaEmployment type: OtherJob DescriptionReq#: 4180About NevroNevro (NYSE: NVRO) is a global medical device company headquartered in Redwood City, California. We are focused on delivering comprehensive, life-changing solutions that continue to set...
-
Redwood City, United States Allakos Inc Full timeSenior/Executive Medical Director, Medical Affairs and Clinical Development– Allergy/GastroenterologyJoin to apply for the Senior/Executive Medical Director, Medical Affairs and Clinical Development– Allergy/Gastroenterology role at Allakos IncSenior/Executive Medical Director, Medical Affairs and Clinical Development– Allergy/Gastroenterology3 weeks...
-
Director Medical Affairs
6 days ago
Redwood City, United States Rezolute Full timeRezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI)...